107 related articles for article (PubMed ID: 1331199)
1. Confirmation of second generation anti-hepatitis C virus enzyme immunoassays by antigenic cross-validation.
Teo CG; Gabriel FG; Mortimer PP
J Clin Pathol; 1992 Oct; 45(10):917-20. PubMed ID: 1331199
[TBL] [Abstract][Full Text] [Related]
2. Peptide based enzyme immunoassays for detecting hepatitis C antibodies in sera of people at high risk.
Gabriel FG; Teo CG
J Clin Pathol; 1994 Apr; 47(4):357-9. PubMed ID: 8027376
[TBL] [Abstract][Full Text] [Related]
3. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus.
Abdel-Hamid M; El-Daly M; El-Kafrawy S; Mikhail N; Strickland GT; Fix AD
J Clin Microbiol; 2002 May; 40(5):1656-9. PubMed ID: 11980937
[TBL] [Abstract][Full Text] [Related]
4. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.
Chaudhary RK; Maclean C
Am J Clin Pathol; 1993 Jun; 99(6):702-4. PubMed ID: 7686716
[TBL] [Abstract][Full Text] [Related]
5. Enzyme immunoassays for anti-hepatitis C virus antibodies improved specificity and analytical sensitivity by combination of three different recombinant viral proteins in second generation tests.
Prohaska W; Schroeter E; Kaars-Wiele P; Kleesiek K
Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):397-404. PubMed ID: 1381965
[TBL] [Abstract][Full Text] [Related]
6. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to hepatitis C virus by second-generation immunoassays in a cohort of patients with bleeding disorders.
Hatzakis A; Polychronaki H; Miriagou V; Yannitsiotis A; Chrispeels J; Troonen H; Karafoulidou A; Gialeraki A; Katsouyanni K; Mandalaki T
Vox Sang; 1992; 63(3):204-9. PubMed ID: 1333137
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of supplemental hepatitis C virus antibody test systems.
Evans CS; Tobler L; Polito A; Stewart J; Chien D; Wilber J; Quan S; Delaney S; Kuo G; Busch MP
Transfusion; 1992 Jun; 32(5):408-14. PubMed ID: 1320780
[TBL] [Abstract][Full Text] [Related]
9. Performance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study.
Tobler LH; Lee SR; Stramer SL; Peterson J; Kochesky R; Watanabe K; Quan S; Polito A; Busch MP
Transfusion; 2000 Aug; 40(8):917-23. PubMed ID: 10960517
[TBL] [Abstract][Full Text] [Related]
10. High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. Viral Hepatitis and AIDS Study Group.
Andreu J; Abad MA; Sanchez-Quijano A; Torronteras R; Luque F; Garcia de las Heras J; Soto B; Pineda JA; Leal M; Lissen E
J Intern Med; 1994 Jul; 236(1):73-7. PubMed ID: 7517430
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus in blood samples from volunteer donors.
Zhang HY; Kuramoto IK; Mamish D; Sazama K; Holland PV; Zeldis JB
J Clin Microbiol; 1993 Mar; 31(3):606-9. PubMed ID: 8384627
[TBL] [Abstract][Full Text] [Related]
12. An algorithm for confirming screen reactivity in blood donors in enzyme immunoassays for antibodies to hepatitis C virus.
Craske J; Paver WK; Farmer D
J Immunol Methods; 1993 Apr; 160(2):227-35. PubMed ID: 7681460
[TBL] [Abstract][Full Text] [Related]
13. Improved detection of antibodies to hepatitis C virus in dialysis patients using a second-generation enzyme immunoassay.
de Medina M; Ortiz C; Krenc C; Leete J; Vallari D; Hill M; LaRue S; Jimenez M; Anderson W; Schiff E
Am J Kidney Dis; 1992 Dec; 20(6):589-91. PubMed ID: 1334368
[TBL] [Abstract][Full Text] [Related]
14. A method for the detection and confirmation of antibodies to hepatitis C virus in dried blood spots.
Parker SP; Cubitt WD; Ades AE
J Virol Methods; 1997 Nov; 68(2):199-205. PubMed ID: 9389410
[TBL] [Abstract][Full Text] [Related]
15. Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNA.
Allain JP; Coghlan PJ; Kenrick KG; Whitson K; Keller A; Cooper GJ; Vallari DS; Delaney SR; Kuhns MC
Blood; 1991 Nov; 78(9):2462-8. PubMed ID: 1657250
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of hepatitis C virus infection using two second-generation enzyme immunoassays with a recombinant immunoblot assay for confirmation.
Schneeberger P; van der Nat H; van Dijk W; van Loon A
Eur J Clin Microbiol Infect Dis; 1994 Feb; 13(2):118-21. PubMed ID: 8013482
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a chimpanzee colony for antibodies to hepatitis C virus.
Lanford RE; Notvall L; Barbosa LH; Eichberg JW
J Med Virol; 1991 Jul; 34(3):148-53. PubMed ID: 1717646
[TBL] [Abstract][Full Text] [Related]
18. Low prevalence of hepatitis C virus infection among dentists in Taiwan.
Kuo MY; Hahn LJ; Hong CY; Kao JH; Chen DS
J Med Virol; 1993 May; 40(1):10-3. PubMed ID: 7685807
[TBL] [Abstract][Full Text] [Related]
19. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hepatitis C virus kits.
Chaudhary RK; Frenette S; Mo T
J Clin Microbiol; 1991 Nov; 29(11):2616-7. PubMed ID: 1723074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
